| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444891 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
mRECIST, a simpler method, provided prognostic values for predicting OS equivalent to EASL criteria in patients with HCC undergoing TACE as an initial treatment modality.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Beom Kyung Kim, Kyung Ah Kim, Jun Yong Park, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han, Seung Up Kim, Myeong-Jin Kim,